Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
4.060
+0.010 (0.25%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Bionano Genomics Revenue
In the year 2024, Bionano Genomics had annual revenue of $30.78M, down -14.79%. Bionano Genomics had revenue of $8.16M in the quarter ending December 31, 2024, a decrease of -23.86%.
Revenue (ttm)
$30.78M
Revenue Growth
-14.79%
P/S Ratio
0.17
Revenue / Employee
$89,465
Employees
344
Market Cap
12.18M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
BNGO News
- 10 days ago - Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM - GlobeNewsWire
- 18 days ago - Bionano Genomics, Inc. (BNGO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 18 days ago - Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025 - GlobeNewsWire
- 25 days ago - Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect - GlobeNewsWire
- 4 weeks ago - Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting - GlobeNewsWire
- 5 weeks ago - Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025 - GlobeNewsWire
- 5 weeks ago - Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML - GlobeNewsWire
- 3 months ago - Bionano Announces Effective Date of Reverse Stock Split - GlobeNewsWire